Consistent and clinically relevant effects with fentanyl buccal tablet in the treatment of patients receiving maintenance opioid therapy and experiencing cancer-related breakthrough pain.

Pain practice : the official journal of World Institute of Pain

Volumn 10, Issue 4, 2010, Pages 287-293

  Zeppetella, Giovambattista ^a   Messina, John ^b   Xie, Fang ^b   Slatkin, Neal E ^b  

^a St Clare Hospice   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NARCOTIC ANALGESIC AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG POTENTIATION; FEMALE; FOLLOW UP; HUMAN; MALE; NEOPLASM; PAIN; PAIN ASSESSMENT; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; TABLET; TIME;

ANALGESICS, OPIOID; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; FEMALE; FENTANYL; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASMS; PAIN; PAIN MEASUREMENT; TABLETS; TIME FACTORS;

EID: 78049374058     PISSN: None     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2010.00359.x     Document Type: Article

References (0)